Picture of SMS Pharmaceuticals logo

SMSPHARMA — SMS Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: SMS Pharmaceuticals says PMDA (Japan) inspection at Bachupally facility concludes with no critical observations

Aug 23 (Reuters) - Sms Pharmaceuticals Ltd  SMSP.NS : 
    * PMDA (Japan) inspection at manufacturing facility - 
unit-II, located at Bachupally, Hyderabad concluded with no 
critical observations 
 
Source text: (http://bit.ly/2wmyq8n) 
Further company coverage:  SMSP.NS  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on SMS Pharmaceuticals

See all news